Insider Transactions in Q2 2023 at Mimedx Group, Inc. (MDXG)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 23
2023
|
Joseph H Capper Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
42,025
+29.59%
|
$252,150
$6.5 P/Share
|
|
Jun 22
2023
|
Joseph H Capper Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
57,975
+50.0%
|
$347,850
$6.33 P/Share
|
|
Jun 13
2023
|
M Kathleen Behrens Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,354
+18.01%
|
$141,416
$4.95 P/Share
|
|
Jun 13
2023
|
James L Bierman Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,354
+18.01%
|
$141,416
$4.95 P/Share
|
|
Jun 13
2023
|
Phyllis Gardner Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,354
+23.2%
|
$141,416
$4.95 P/Share
|
|
Jun 13
2023
|
Cato T Laurencin Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,354
+21.36%
|
$141,416
$4.95 P/Share
|
|
Jun 13
2023
|
Todd Newton Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,354
+8.92%
|
$141,416
$4.95 P/Share
|
|
Jun 13
2023
|
William A Hawkins Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,354
+18.85%
|
$141,416
$4.95 P/Share
|
|
Jun 13
2023
|
Michael J Giuliani Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,354
+21.36%
|
$141,416
$4.95 P/Share
|
|
May 16
2023
|
Robert Benjamin Stein President, Regenerative Med. |
SELL
Open market or private sale
|
Direct |
10,365
-3.16%
|
$51,825
$5.95 P/Share
|
|
May 15
2023
|
Robert Benjamin Stein President, Regenerative Med. |
SELL
Open market or private sale
|
Direct |
3,607
-1.09%
|
$21,642
$6.15 P/Share
|
|
May 10
2023
|
Robert Benjamin Stein President, Regenerative Med. |
SELL
Open market or private sale
|
Direct |
5,869
-1.74%
|
$29,345
$5.93 P/Share
|
|
May 10
2023
|
William Frank Iv Hulse General Counsel and CAO |
SELL
Open market or private sale
|
Direct |
5,870
-1.27%
|
$29,350
$5.93 P/Share
|
|
May 10
2023
|
Peter M Carlson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,976
-0.9%
|
$29,880
$5.93 P/Share
|
|
May 10
2023
|
William Lawrence Phelan Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,595
-0.86%
|
$7,975
$5.93 P/Share
|
|
May 04
2023
|
Robert Benjamin Stein President, Regenerative Med. |
SELL
Open market or private sale
|
Direct |
51,756
-13.29%
|
$258,780
$5.34 P/Share
|
|
May 02
2023
|
William Lawrence Phelan Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
5,200
-2.72%
|
$15,600
$3.8 P/Share
|
|
Apr 25
2023
|
William Lawrence Phelan Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,628
-0.85%
|
$4,884
$3.74 P/Share
|
|
Apr 25
2023
|
Peter M Carlson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,094
-0.91%
|
$18,282
$3.74 P/Share
|
|
Apr 25
2023
|
William Frank Iv Hulse General Counsel and CAO |
SELL
Open market or private sale
|
Direct |
5,988
-1.28%
|
$17,964
$3.74 P/Share
|
|
Apr 25
2023
|
Robert Benjamin Stein President, Regenerative Med. |
SELL
Open market or private sale
|
Direct |
5,987
-1.51%
|
$17,961
$3.74 P/Share
|
|
Apr 11
2023
|
Robert Benjamin Stein President, Regenerative Med. |
SELL
Open market or private sale
|
Direct |
5,996
-1.49%
|
$17,988
$3.31 P/Share
|
|
Apr 11
2023
|
William Lawrence Phelan Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,632
-0.84%
|
$4,896
$3.31 P/Share
|
|
Apr 11
2023
|
Peter M Carlson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,100
-0.9%
|
$18,300
$3.31 P/Share
|
|
Apr 11
2023
|
William Frank Iv Hulse General Counsel and CAO |
SELL
Open market or private sale
|
Direct |
5,995
-1.26%
|
$17,985
$3.31 P/Share
|